dc.contributor.author | Zafar, Saba | |
dc.contributor.author | Rasul, Akhtar | |
dc.contributor.author | Iqbal, Muhammad Shahid | |
dc.contributor.author | Rasool, Maria | |
dc.contributor.author | Ahmed, Bilal | |
dc.contributor.author | Qadir, Muhammad Imran | |
dc.date.accessioned | 2022-10-20T10:00:06Z | |
dc.date.available | 2022-10-20T10:00:06Z | |
dc.date.issued | 2021-01-16 | |
dc.identifier.issn | 1011-601X | |
dc.identifier.uri | http://142.54.178.187:9060/xmlui/handle/123456789/13441 | |
dc.description.abstract | : The role of nanobiotechnology in the treatment of diseases is limitless. In this review we tried to focus main aspects of nanotechnology in drug carrier systems for treatment and diagnosis of various diseases such as cancer, pulmonary diseases, infectious diseases, vaccine development, diabetes mellitus and the role of nanotechnology on our economy and its positive social impacts on our community. We discussed here about the different “Biotechnano Strategies” to develop new avenues and ultimately improve the treatment of multiple diseases. | en_US |
dc.language.iso | en | en_US |
dc.publisher | Karachi: Faculty of Pharmacy & Pharmaceutical Sciecnes, University of Karachi | en_US |
dc.subject | Nanochemical products | en_US |
dc.subject | infectious diseases | en_US |
dc.subject | vaccines | en_US |
dc.title | Nanobiotechnology: Cradle for revolution in drug carrier systems | en_US |
dc.type | Article | en_US |